Who commented on Expansion of the Abbreviated 510(k) Program: Demonstrating Substantial Equivalence through Performance Criteria; Draft Guidance for Industry and Food and Drug Administration Staff; Availability?

Question

Who commented on Expansion of the Abbreviated 510(k) Program:  Demonstrating Substantial Equivalence through Performance Criteria; Draft Guidance for Industry and Food and Drug Administration Staff; Availability?

Accepted Answer

3 organizations filed 5 public comments on Expansion of the Abbreviated 510(k) Program:  Demonstrating Substantial Equivalence through Performance Criteria; Draft Guidance for Industry and Food and Drug Administration Staff; Availability (FDA-2018-D-1387) on regulations.gov.

Expansion of the Abbreviated 510(k) Program: Demonstrating Substantial Equivalence through Performance Criteria; Draft Guidance for Industry and Food and Drug Administration Staff; Availability

Commenters (3)